Profile
Kevin Siver worked as an Executive Director-External Quality at Amgen, Inc. He also worked as a Vice President-Quality at Elicio Therapeutics, Inc. (Old) from 2021 to 2022.
Dr. Siver completed his undergraduate degree at Southern University & A&M College and earned a doctorate degree from the University of Florida.
Former positions of Kevin Siver
| Companies | Position | End |
|---|---|---|
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/11/2022 |
| AMGEN INC. | Corporate Officer/Principal | - |
Training of Kevin Siver
| University of Florida | Doctorate Degree |
| Southern University & A&M College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Kevin Siver
